Short interest in PhaseBio Pharmaceuticals Inc (OTC:PHASQ) decreased during the last reporting period, falling from 248.68K to 248.68K. This put 0.61% of the company's publicly available shares short.

Short interest for PhaseBio Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of PhaseBio Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 22.00 shares traded per day, it would take 999.99 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.